Gts Securities LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.81 - $5.78 $101,971 - $122,536
21,200 Added 37.99%
77,000 $439,000
Q1 2024

May 15, 2024
SELL
$4.93 - $9.31 $697,595 - $1.32 Million
-141,500 Reduced 71.72%
55,800 $279,000
Q4 2023

Feb 14, 2024
SELL
$7.13 - $9.49 $10,695 - $14,235
-1,500 Reduced 0.75%
197,300 $1.77 Million
Q3 2023

Nov 15, 2023
BUY
$7.77 - $12.27 $1.54 Million - $2.44 Million
198,800 New
198,800 $1.54 Million

Others Institutions Holding AUPH

# of Institutions
191
Shares Held
56.2M
Call Options Held
499K
Put Options Held
637K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.04B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email